Cargando…
Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent metabolic disorder with steadily increasing incidence rates worldwide, especially in the West. There are no drugs available at present to treat NAFLD, and the primary therapeutic options include weight loss and the combination of health...
Autores principales: | Chen, Hui-Ting, Huang, Hong-Li, Li, Yong-Qiang, Xu, Hao-Ming, Zhou, Yong-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201149/ https://www.ncbi.nlm.nih.gov/pubmed/32390701 http://dx.doi.org/10.3748/wjg.v26.i16.1901 |
Ejemplares similares
-
Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017) -
Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022) -
Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017) -
Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome
por: Sheng, Wei, et al.
Publicado: (2022) -
Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
por: Kalogirou, Maria Styliani, et al.
Publicado: (2022)